Efficacy of Tirzepatide, Retatrutide, and Semaglutide for Weight Loss in Obese Individuals Without Diabetes

Acad Emerg Med. 2025 Nov;32(11):1255-1258. doi: 10.1111/acem.70088. Epub 2025 Jun 29.

Authors

Bastu Adebayo Olowo-Oribi¹, Richard James Salway²

Affiliations

¹ Department of Emergency Medicine, New York City Health + Hospitals/Kings County/State University of New York, Downstate Health Sciences University, Brooklyn, New York, USA.
² Department of Emergency Medicine, New York City Health + Hospitals/Kings County, Brooklyn, New York, USA.

PMID: 40583149
DOI: 10.1111/acem.70088

No abstract available

Keywords: GIP and GCG receptor agonists; GLP‐1 receptor agonist; diabetes; obesity; weight loss.

Publication types

Review